… Our analyses demonstrated that the safety profile of omalizumab was excellent and the …
and safe when administered at recommended dosages. In our meta-analysis, omalizumab-…

… We undertook the meta-analysis to assess the efficacy and safety of omalizumab in AR by
… In summary, omalizumab was relatively safe in the treatment of AR. The results are shown …

… Omalizumab (Oma) is an anti-IgE monoclonal antibody, whose clinical and real-life data
demonstrate safety … by meta-analysis, were to evaluate the effectiveness and safety of Oma in …

… In this meta-analysis, three studies with 1380 children … and safety of omalizumab were
included. We found that patients with … In the current analysis, long-term treatment with omalizumab …

… of omalizumab dosages and … safety of omalizumab in adolescents are less strongly
demonstrated in this review. Unfortunately, we could not find a trial indicating the use of omalizumab …

… We aimed to assess the efficacy and safety of omalizumab in … RCTs evaluating the safety
and efficacy of omalizumab in AR. … the efficacy and safety of omalizumab in the management of …

… We searched for randomized trials that assessed the safety and efficacy of omalizumab
in AR. We searched PubMed (last search, September 2013) by using the term “…

… Based on these considerations, the aim of this study was to perform a meta-analysis of all
the available literature to obtain updated evidence on the efficacy and safety of omalizumab for …

… We sought to assess the efficacy and safety of different doses of omalizumab for the …
This meta-analysis investigated the efficacy and safety of different doses of omalizumab in the …

… the first meta-analysis that identified omalizumab significantly improved endoscopic, clinical
and patient-reported outcomes in moderate to severe CRSwNP and it was safe and well …